Granaticin
Granaticin A inhibits the initial stage of RNA biosynthesis, has anti-Gram-positive bacteria, Mycobacterium (weak) and Vaginal trichomonas activity, but also can inhibit tumor cells.
For research use only. We do not sell to patients.
- CAS No.: 19879-06-2
- Formula: C22H20O10
- Molecular Weight:444.39
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
1.3 μM
Compound: Granaticin A
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 25153802] |
| HCT-116 | IC50 |
11 μM
Compound: Granaticin A
|
Cytotoxicity against human HCT116 cells by MTT assay
Cytotoxicity against human HCT116 cells by MTT assay
|
[PMID: 25153802] |
| HeLa | IC50 |
0.7 μM
Compound: Granaticin A
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 25153802] |
| HepG2 | IC50 |
6.6 μM
Compound: Granaticin A
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 25153802] |
Chemical Information
-
CAS No. 19879-06-2
-
Molecular Weight 444.39
-
Formula C22H20O10
-
SMILES
O[C@@]12C3=C(O)C(C(C4=C([C@@]5([H])[C@@](CC(O5)=O)([H])O[C@H]4C)C6=O)=O)=C6C(O)=C3[C@@](O[C@@H]2C)([H])C[C@H]1O
-
Synonyms
Granaticin A; Litmomycin
-
Structure Classification
-
Initial Source
Streptomyces sp. 166
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)